We are a microbiome therapeutics platform company developing a novel class of biological drugs, which we refer to as Ecobiotic microbiome therapeutics. The human microbiome is an ecology of microorganisms, including bacteria, fungi and viruses, that, when unhealthy, or dysbiotic, can leave the body more susceptible to infections, metabolic disorders, allergies, autoimmune disease, inflammation and other serious conditions. Our drugs are designed to restore health by repairing the function of a dysbiotic microbiome. We are initially focused on implementing our microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome, one of the most diverse microbiomes in the human body.
3 salaries reported
$98,221 per year
Our mission is to transform the lives of patients worldwide with revolutionary microbiome-based therapeutics.
Seres Therapeutics is creating a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis
New insights into the human microbiome are fundamentally reshaping how we understand and treat a wide range of diseases, creating new possibilities for patients not served by current approaches. We are a clinical biopharmaceutical company with a powerful platform to discover and develop drugs to treat diseases in multiple areas of medicine that arise from dysbiosis.
Our team of drug development experts discovers and designs new medicines using our proprietary microbiome therapeutics platform.
We pinpoint functional differences between a healthy and dysbiotic microbiome, and rationally design potential Ecobiotic® drugs. These therapeutics are ecological compositions made up of beneficial organisms that are designed to target functional deficiencies and reestablish keystone features of a healthy microbiome. Our discovery efforts currently span metabolic, inflammatory, and infectious diseases.
Founded: 2010 by Flagship VentureLabs®
Location: Cambridge, MA
Our Name: Seres is the plural noun of the word Sere, defined as a series of ecological communities formed in ecological succession
CEO: Roger Pomerantz, M.D.
Lead Program: SER-109 for the prevention of recurrent Clostridium difficile infection; designated Breakthrough Therapy by FDA – less